Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
271.3 EUR | 0.00% |
|
-1.17% | -10.17% |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company benefits from high valuations in earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-10.17% | 17.2B | - | ||
+6.37% | 213B | B | ||
+10.21% | 184B | B- | ||
+28.22% | 153B | B- | ||
+34.42% | 113B | A- | ||
+0.80% | 63.66B | A- | ||
+19.21% | 53.53B | B+ | ||
+0.13% | 49.11B | B+ | ||
-4.16% | 38.73B | A | ||
+2.39% | 36.26B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- WAT Stock
- WAZ Stock
- Ratings Waters Corporation